Cargando…
Bone marrow-derived mesenchymal stem cells inhibit the proliferation of hepatic stellate cells by inhibiting the transforming growth factor β pathway
Bone marrow-derived mesenchymal stem cells (BM-MSCs) are considered to be a potential therapy for end-stage liver disease. However, the therapeutic mechanism of BM-MSCs remains unclear. The aim of the current study was to investigate the role of paracrine signaling in BM-MSCs in liver cirrhosis in v...
Autores principales: | ZHANG, LI-TING, FANG, XUE-QIN, CHEN, QING-FENG, CHEN, HONG, XIAO, PING, PENG, XUE-BIN, ZHANG, SHENG-XIANG, LI, JUN-FENG, MAO, XIAO-RONG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626145/ https://www.ncbi.nlm.nih.gov/pubmed/26458849 http://dx.doi.org/10.3892/mmr.2015.4362 |
Ejemplares similares
-
Human umbilical cord mesenchymal stem cells inhibit proliferation of hepatic stellate cells in vitro
por: Zhang, Li-Ting, et al.
Publicado: (2018) -
Inhibition of hepatic stellate cell proliferation by bone marrow mesenchymal stem cells via regulation of the cell cycle in rat
por: QIN, SHANYU, et al.
Publicado: (2012) -
Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis
por: Jang, Yoon Ok, et al.
Publicado: (2015) -
Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition
por: Liu, Jingmei, et al.
Publicado: (2023) -
Babao Dan attenuates hepatic fibrosis by inhibiting hepatic stellate cells activation and proliferation via TLR4 signaling pathway
por: Liang, Lei, et al.
Publicado: (2016)